Article Information
History
- February 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- I. Howell1,*,
- F. Yang2,3,
- V. Brown4,
- J. Cane1,
- E. Marchi1,
- A Azim5,
- J. Busby4,
- P.J. McDowell4,
- S.E. Diver6,
- C. Borg1,
- L. G. Heaney4,
- I. D. Pavord1,
- C. E. Brightling6,
- R. Chaudhuri2 and
- T.S.C. Hinks1
- 1Respiratory Medicine Unit, Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom & National Institute for Health Research Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK
- 2University of Glasgow, Glasgow, UK
- 3The National Heart and Lung Institute, Imperial college London, London, UK
- 4Queen’s University Belfast, Belfast, UK
- 5Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories and NIHR Southampton Respiratory Biomedical Research Unit, Southampton University, Southampton, UK
- 6Institute for Lung Health, Leicester NIHR BRC, University of Leicester, Leicester, UK
- ↵*Corresponding author; email: imran.howell{at}ndm.ox.ac.uk
Posted February 15, 2024.
Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis
